 Fernando PEREIRA BESERRA
Concepts (94)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Wound Healing | 4 | 2022 | 268 | 2.460 |
Why?
| | Pentacyclic Triterpenes | 3 | 2020 | 13 | 2.100 |
Why?
| | Plant Extracts | 4 | 2022 | 158 | 1.800 |
Why?
| | Re-Epithelialization | 2 | 2023 | 2 | 1.780 |
Why?
| | Fabaceae | 2 | 2023 | 7 | 1.780 |
Why?
| | Phytotherapy | 2 | 2022 | 67 | 1.520 |
Why?
| | Rats, Wistar | 7 | 2023 | 392 | 0.920 |
Why?
| | Anti-Inflammatory Agents | 4 | 2023 | 456 | 0.920 |
Why?
| | Phytochemicals | 1 | 2022 | 7 | 0.840 |
Why?
| | Stomach Ulcer | 3 | 2018 | 9 | 0.820 |
Why?
| | Neovascularization, Physiologic | 2 | 2020 | 178 | 0.780 |
Why?
| | Wounds, Penetrating | 1 | 2022 | 68 | 0.770 |
Why?
| | Skin | 2 | 2023 | 655 | 0.760 |
Why?
| | Ki-67 Antigen | 1 | 2020 | 106 | 0.720 |
Why?
| | Antioxidants | 3 | 2022 | 552 | 0.720 |
Why?
| | Dermatologic Agents | 1 | 2020 | 57 | 0.710 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 2 | 2022 | 300 | 0.710 |
Why?
| | NF-kappa B | 2 | 2020 | 634 | 0.690 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2020 | 355 | 0.650 |
Why?
| | Anti-Ulcer Agents | 2 | 2015 | 16 | 0.650 |
Why?
| | Collagen | 1 | 2020 | 427 | 0.620 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2019 | 179 | 0.610 |
Why?
| | Oxidative Stress | 3 | 2019 | 1151 | 0.580 |
Why?
| | Diabetic Angiopathies | 1 | 2019 | 259 | 0.580 |
Why?
| | Plants, Medicinal | 1 | 2016 | 18 | 0.570 |
Why?
| | Cytokines | 3 | 2022 | 1855 | 0.570 |
Why?
| | Sapindaceae | 1 | 2015 | 1 | 0.530 |
Why?
| | Hyperglycemia | 1 | 2019 | 308 | 0.530 |
Why?
| | Rats | 6 | 2023 | 5177 | 0.530 |
Why?
| | Pancreas | 1 | 2016 | 277 | 0.480 |
Why?
| | Terpenes | 2 | 2018 | 23 | 0.430 |
Why?
| | Cell Proliferation | 1 | 2018 | 2232 | 0.390 |
Why?
| | Hypoglycemic Agents | 1 | 2016 | 1024 | 0.330 |
Why?
| | Cyclohexenes | 1 | 2018 | 6 | 0.320 |
Why?
| | Diabetes Mellitus | 1 | 2016 | 927 | 0.320 |
Why?
| | Animals | 10 | 2023 | 32702 | 0.280 |
Why?
| | Antidiarrheals | 2 | 2016 | 15 | 0.270 |
Why?
| | Metabolic Syndrome | 1 | 2018 | 381 | 0.230 |
Why?
| | Administration, Topical | 1 | 2022 | 139 | 0.200 |
Why?
| | Gastric Mucosa | 3 | 2018 | 44 | 0.200 |
Why?
| | Gene Expression Regulation | 3 | 2020 | 2405 | 0.200 |
Why?
| | Skin Physiological Phenomena | 1 | 2020 | 28 | 0.190 |
Why?
| | Administration, Cutaneous | 1 | 2020 | 118 | 0.180 |
Why?
| | Models, Animal | 1 | 2022 | 347 | 0.180 |
Why?
| | Lipids | 1 | 2023 | 584 | 0.180 |
Why?
| | Keratin-16 | 1 | 2018 | 2 | 0.170 |
Why?
| | Receptor, TIE-2 | 1 | 2018 | 12 | 0.170 |
Why?
| | Matrix Metalloproteinase 2 | 1 | 2018 | 56 | 0.160 |
Why?
| | Regeneration | 1 | 2020 | 163 | 0.160 |
Why?
| | Protective Agents | 1 | 2018 | 41 | 0.160 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2018 | 261 | 0.150 |
Why?
| | Plant Leaves | 2 | 2016 | 118 | 0.150 |
Why?
| | Signal Transduction | 2 | 2022 | 4605 | 0.150 |
Why?
| | Keratinocytes | 1 | 2018 | 227 | 0.150 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2018 | 407 | 0.140 |
Why?
| | Cissus | 1 | 2016 | 1 | 0.140 |
Why?
| | Toxicity Tests, Acute | 1 | 2015 | 9 | 0.130 |
Why?
| | Male | 7 | 2022 | 56636 | 0.130 |
Why?
| | Medicine, Traditional | 1 | 2015 | 23 | 0.130 |
Why?
| | Edema | 1 | 2016 | 122 | 0.130 |
Why?
| | Cell Movement | 1 | 2018 | 879 | 0.120 |
Why?
| | Duodenal Ulcer | 1 | 2013 | 9 | 0.120 |
Why?
| | Flavoring Agents | 1 | 2013 | 8 | 0.120 |
Why?
| | Fibroblasts | 1 | 2018 | 835 | 0.120 |
Why?
| | RNA, Messenger | 1 | 2020 | 2627 | 0.110 |
Why?
| | Intestines | 1 | 2016 | 328 | 0.110 |
Why?
| | Inflammation | 1 | 2020 | 2523 | 0.090 |
Why?
| | Disease Models, Animal | 2 | 2016 | 3626 | 0.080 |
Why?
| | Treatment Outcome | 1 | 2022 | 9212 | 0.080 |
Why?
| | Antineoplastic Agents, Phytogenic | 1 | 2018 | 180 | 0.070 |
Why?
| | Analgesics | 1 | 2018 | 159 | 0.070 |
Why?
| | Peroxidase | 2 | 2018 | 150 | 0.070 |
Why?
| | Anti-Bacterial Agents | 1 | 2015 | 1498 | 0.070 |
Why?
| | Plants | 1 | 2018 | 209 | 0.070 |
Why?
| | Osteoarthritis | 1 | 2018 | 177 | 0.070 |
Why?
| | Glutathione | 2 | 2018 | 314 | 0.060 |
Why?
| | Time Factors | 1 | 2015 | 6248 | 0.060 |
Why?
| | Mice | 2 | 2016 | 15289 | 0.050 |
Why?
| | Ethanol | 2 | 2018 | 570 | 0.050 |
Why?
| | Humans | 3 | 2018 | 116809 | 0.040 |
Why?
| | Gastritis | 1 | 2018 | 81 | 0.040 |
Why?
| | Superoxide Dismutase | 1 | 2018 | 337 | 0.040 |
Why?
| | Xylenes | 1 | 2016 | 7 | 0.030 |
Why?
| | Administration, Oral | 1 | 2018 | 744 | 0.030 |
Why?
| | Dinoprostone | 1 | 2016 | 190 | 0.030 |
Why?
| | Cysteamine | 1 | 2013 | 5 | 0.030 |
Why?
| | Pylorus | 1 | 2013 | 11 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2018 | 1893 | 0.030 |
Why?
| | Mucus | 1 | 2013 | 54 | 0.030 |
Why?
| | Duodenum | 1 | 2013 | 65 | 0.030 |
Why?
| | Stomach | 1 | 2013 | 102 | 0.030 |
Why?
| | Reperfusion Injury | 1 | 2013 | 250 | 0.020 |
Why?
| | Female | 1 | 2015 | 60542 | 0.020 |
Why?
| | Nitric Oxide | 1 | 2013 | 877 | 0.020 |
Why?
|
|
PEREIRA BESERRA's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|